[HTML][HTML] Editor's choice–management of the diseases of mesenteric arteries and veins: clinical practice guidelines of the European Society of Vascular Surgery (ESVS)
M Björck, M Koelemay, S Acosta, FB Goncalves… - European Journal of …, 2017 - Elsevier
Dedication These guidelines are dedicated to Paola De Rango, University of Perugia, Italy.
She participated very actively in the process of developing these guidelines, in particular the …
She participated very actively in the process of developing these guidelines, in particular the …
The coagulopathy of chronic liver disease
A Tripodi, PM Mannucci - New England Journal of Medicine, 2011 - Mass Medical Soc
The Coagulopathy of Chronic Liver Disease | NEJM Skip to main content NEJM Group Follow
Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …
Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis
BACKGROUND & AIMS: We performed a randomized controlled trial to evaluate the safety
and efficacy of enoxaparin, a low-molecular-weight heparin, in preventing portal vein …
and efficacy of enoxaparin, a low-molecular-weight heparin, in preventing portal vein …
Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis
M Senzolo, T M. Sartori, V Rossetto, P Burra… - Liver …, 2012 - Wiley Online Library
Background There is no established management algorithm for portal vein thrombosis (PVT)
in cirrhotic patients. The aim of our study was to prospectively evaluate anticoagulation and …
in cirrhotic patients. The aim of our study was to prospectively evaluate anticoagulation and …
Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis
I Pettinari, R Vukotic, H Stefanescu… - Official journal of the …, 2019 - journals.lww.com
Objectives: Portal vein thrombosis (PVT) is a frequent complication of cirrhosis. Benefit,
safety, and duration of anticoagulant treatment in this setting are controversial issues. The …
safety, and duration of anticoagulant treatment in this setting are controversial issues. The …
Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis
V Hernández-Gea, A De Gottardi, FWG Leebeek… - Journal of …, 2019 - Elsevier
Budd-Chiari syndrome and non-cirrhotic non-tumoral portal vein thrombosis are 2 rare
disorders, with several similarities that are categorized under the term splanchnic vein …
disorders, with several similarities that are categorized under the term splanchnic vein …
Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis
Y Nagaoki, H Aikata, K Daijyo, Y Teraoka… - Hepatology …, 2018 - Wiley Online Library
Aim To compare the efficacy and safety of edoxaban and warfarin for treatment of portal vein
thrombosis (PVT) following danaparoid sodium in patients with liver cirrhosis. Methods Fifty …
thrombosis (PVT) following danaparoid sodium in patients with liver cirrhosis. Methods Fifty …
Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis
A Tripodi, M Primignani, L Lemma, V Chantarangkul… - Journal of …, 2013 - Elsevier
Background & Aims Cirrhosis is associated with a plasmatic procoagulant imbalance,
detected in vitro by thrombin generation tests performed in the presence vs. absence of such …
detected in vitro by thrombin generation tests performed in the presence vs. absence of such …
Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review
TC Hall, G Garcea, M Metcalfe, D Bilku… - World journal of …, 2011 - Springer
Background No definitive evidence exists regarding the treatment of acute portal vein
thrombosis (PVT). Treatment modalities described include conservative management …
thrombosis (PVT). Treatment modalities described include conservative management …
Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation
KT Werner, S Sando, EJ Carey, HE Vargas… - Digestive diseases and …, 2013 - Springer
Background The prevalence of portal vein thrombosis (PVT) increases with the severity of
liver disease. Development of PVT is often accompanied by increased rate of morbidity and …
liver disease. Development of PVT is often accompanied by increased rate of morbidity and …